Jump Financial’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
PCM
Jump Financial's EBS Position: Q1 2026 in Review
Jump Financial sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 42,142 shares — an estimated $521K sold.
Jump Financial first reported a position in EBS in Q3 2020 and held it in 11 quarters. The position peaked at $2.77M in Q3 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Jump Financial reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
- Jump Financial sold 42,142 Emergent Biosolutions shares in Q1 2026, an estimated $521K.
- Jump Financial first reported a position in Emergent Biosolutions in Q3 2020 and held it in 11 quarters.
- Jump Financial's Emergent Biosolutions position peaked at $2.77M in Q3 2025.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.